Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krook, H.
Right arrow Articles by Korsgren, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krook, H.
Right arrow Articles by Korsgren, O.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 51:79-86, 2002
© 2002 by the American Diabetes Association, Inc.

A Distinct Th1 Immune Response Precedes the Described Th2 Response in Islet Xenograft Rejection

Henrik Krook1, Anette Hagberg2, Zhenshun Song3, Ulf Landegren2, Lars Wennberg3, and Olle Korsgren1

1 Division of Clinical Immunology, Uppsala University, Uppsala, Sweden
2 Division of Medical Genetics, Uppsala University, Uppsala, Sweden
3 Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Huddinge, Sweden

Previous studies using semiquantitative reverse transcription–polymerase chain reaction (RT-PCR) have demonstrated that islet xenograft rejection in mice is dominated by Th2-associated cytokines, i.e., interleukin (IL)-4 and IL-10. However, immunohistochemical stainings show that the morphological pattern in this model is more reminiscent of a delayed-type hypersensitivity (DTH) reaction, which is associated with a Th1 response. This study was designed to resolve the mechanisms of acute cellular xenograft rejection in rats transplanted with fetal porcine islet-like cell clusters (ICCs). Real-time quantitative RT-PCR was used to quantify the mRNA expression of cytokines in the grafts and lymph nodes, and the findings were related to the immunopathology of the rejecting grafts. By day 1, mRNA expression levels of IL-1ß, IL-2, IL-12p40, interferon-{gamma}, and tumor necrosis factor-{alpha} were already induced in the lymph nodes. From days 3 to 12, an increasing amount of activated macrophages was seen in the grafts, whereas T- and NK-cells were fewer and mainly accumulated in the periphery of the grafts. Most of the ICCs were rejected by day 5. Transcripts of Th1-associated cytokines were dominant in both regional lymph nodes and in the grafts, with peak levels on days 3 and 5, respectively. The mRNA expression of IL-4 was increased on day 12, and it correlated with the infiltration of eosinophils and an increased level of xenoreactive IgG. The data presented indicate that an islet xenograft triggers a sequential activation of 1) a Th1-associated response characterized by graft destruction in a DTH-like reaction and then 2) a subsequent Th2-associated response characterized by increased levels of xenoreactive antibodies.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. G. Helwig, T. I. Musch, R. A. Craig, and M. J. Kenney
Increased interleukin-6 receptor expression in the paraventricular nucleus of rats with heart failure
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1165 - R1173.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. K. Ganta, B. G. Helwig, F. Blecha, R. R. Ganta, R. Cober, S. Parimi, T. I. Musch, R. J. Fels, and M. J. Kenney
Hypothermia-enhanced splenic cytokine gene expression is independent of the sympathetic nervous system
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R558 - R565.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. K. Ganta, N. Lu, B. G. Helwig, F. Blecha, R. R. Ganta, L. Zheng, C. R. Ross, T. I. Musch, R. J. Fels, and M. J. Kenney
Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1683 - H1691.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
F. Al-Mohanna, S. Saleh, R. S. Parhar, K. Khabar, and K. Collison
Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: the occult role of neutrophils in xenograft rejection revealed
J. Leukoc. Biol., July 1, 2005; 78(1): 51 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
C. K. Ganta, F. Blecha, R. R. Ganta, B. G. Helwig, S. Parimi, N. Lu, R. J. Fels, T. I. Musch, and M. J. Kenney
Hyperthermia-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system
Physiol Genomics, October 4, 2004; 19(2): 175 - 183.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Schmidt, H. Krook, A. Maeda, O. Korsgren, and B. Benda
A New Murine Model of Islet Xenograft Rejection: Graft Destruction Is Dependent on a Major Histocompatibility-Specific Interaction Between T-Cells and Macrophages
Diabetes, May 1, 2003; 52(5): 1111 - 1118.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.